These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 19157446
1. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments. Sun B, Moibi JA, Mak A, Xiao Z, Roa W, Moore RB. J Urol; 2009 Mar; 181(3):1361-71. PubMed ID: 19157446 [Abstract] [Full Text] [Related]
2. The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma. Duggan BJ, Maxwell P, Kelly JD, Canning P, Anderson NH, Keane PF, Johnston SR, Williamson KE. J Urol; 2001 Sep; 166(3):1098-105. PubMed ID: 11490306 [Abstract] [Full Text] [Related]
3. Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides. Lebedeva I, Raffo A, Rando R, Ojwang J, Cossum P, Stein CA. J Urol; 2001 Aug; 166(2):461-9. PubMed ID: 11458048 [Abstract] [Full Text] [Related]
4. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation. Sonnemann J, Gekeler V, Sagrauske A, Müller C, Hofmann HP, Beck JF. Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570 [Abstract] [Full Text] [Related]
5. Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells. Papageorgiou A, Lashinger L, Millikan R, Grossman HB, Benedict W, Dinney CP, McConkey DJ. Cancer Res; 2004 Dec 15; 64(24):8973-9. PubMed ID: 15604261 [Abstract] [Full Text] [Related]
6. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. King ED, Matteson J, Jacobs SC, Kyprianou N. J Urol; 1996 Jan 15; 155(1):316-20. PubMed ID: 7490878 [Abstract] [Full Text] [Related]
8. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Ndozangue-Touriguine O, Sebbagh M, Mérino D, Micheau O, Bertoglio J, Bréard J. Oncogene; 2008 Oct 09; 27(46):6012-22. PubMed ID: 18560353 [Abstract] [Full Text] [Related]
9. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Meslin F, Hamaï A, Gao P, Jalil A, Cahuzac N, Chouaib S, Mehrpour M. Cancer Res; 2007 Nov 15; 67(22):10910-9. PubMed ID: 18006836 [Abstract] [Full Text] [Related]
12. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Lippa MS, Strockbine LD, Le TT, Branstetter DG, Strathdee CA, Holland PM. Apoptosis; 2007 Aug 15; 12(8):1465-78. PubMed ID: 17440816 [Abstract] [Full Text] [Related]
13. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma. Kim R, Tanabe K, Uchida Y, Emi M, Toge T. Int J Mol Med; 2003 Jun 15; 11(6):799-804. PubMed ID: 12736725 [Abstract] [Full Text] [Related]
15. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury. Chen F, Zhang G, Cao Y, Payne R, See WA. J Urol; 2007 Nov 15; 178(5):2166-70. PubMed ID: 17870116 [Abstract] [Full Text] [Related]
16. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist. Griffith TS, Kucaba TA, O'Donnell MA, Burns J, Benetatos C, McKinlay MA, Condon S, Chunduru S. Apoptosis; 2011 Jan 15; 16(1):13-26. PubMed ID: 20734142 [Abstract] [Full Text] [Related]
18. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression. Lee JT, Lee TJ, Park JW, Kwon TK. Int J Oncol; 2009 May 15; 34(5):1455-60. PubMed ID: 19360359 [Abstract] [Full Text] [Related]
20. Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guérin in transitional cancer cell lines. Sandes E, Lodillinsky C, Cwirenbaum R, Argüelles C, Casabé A, Eiján AM. Int J Mol Med; 2007 Dec 15; 20(6):823-8. PubMed ID: 17982689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]